文献速递肝病

肝脏衰弱指数改善对肝硬化患者主观临床医生评估的死亡预测

The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2017-12-12

研究纳入529例等待肝移植的肝硬化门诊患者,比较客观肝脏衰弱指数(LFI)与主观肝病医生评估对等待名单死亡(死亡/因病除名)的预测能力。LFI与临床评估相关性 modest(ρ=0.38),两者均与调整后等待名单死亡风险相关(LFI HR 2.2,95%CI 1.7-2.9;临床评估 HR 1.6,95%CI 1.3-1.9;P<0.01)。在临床评估基础上加入LFI显著改善死亡预测(C统计量0.74 vs 0.68;P=0.02),并正确重分类34%(95%CI 8-53%)的患者。

要点

  • LFI与肝病医生主观评估相关性仅ρ=0.38,且不同医生间变异大(ρ=0.26-0.70)。
  • LFI(HR 2.2)和临床评估(HR 1.6)均与调整后等待名单死亡风险独立相关(P<0.01)。
  • 临床评估加入LFI后死亡预测C统计量从0.68升至0.74(P=0.02),34%患者被正确重分类。

核心结论

  • 主观临床医生评估可预测肝硬化患者等待名单死亡,但主观且因肝病医生而异。
  • 在主观临床医生评估基础上加入LFI显著改善死亡风险预测,并正确重分类34%的患者。
  • 作者数据强烈支持将客观LFI纳入评估,以强化肝硬化患者评估并改善决策。

研究设计与样本

  • 研究纳入529例等待肝移植的肝硬化门诊患者,均接受客观LFI测量和主观临床医生评估。
  • 采用Spearman相关分析LFI与临床评估的关联,Cox回归分析等待名单死亡(死亡/因病除名),C统计量评估判别能力,净重分类指数评估加入LFI后的正确重分类比例。

主要发现

  • 529例患者中,LFI中位数3.8(范围1.0-7.0),临床评估中位数3(范围0-5)。
  • LFI与临床评估相关性 modest(ρ=0.38),不同肝病医生间变异大(ρ=0.26-0.70)。
  • 中位随访11个月,102例(19%)死亡/被除名。
  • LFI(HR 2.2,95%CI 1.7-2.9)和临床评估(HR 1.6,95%CI 1.3-1.9)均与调整后等待名单死亡风险相关(P<0.01)。
  • 临床评估加入LFI后死亡预测C统计量0.74 vs 0.68(P=0.02),正确重分类34%(95%CI 8-53%)的患者。

临床怎么用

  • 作者数据强烈支持将客观LFI纳入肝硬化患者评估,以强化评估并改善决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Frailty, a critical determinant of health outcomes, is most commonly assessed in patients with cirrhosis by general clinician assessment that is limited by its subjectivity. We aimed to compare the objective Liver Frailty Index (LFI), consisting of three performance-based tests (grip, chair stands, balance), with a subjective hepatologist assessment. METHODS: Outpatients with cirrhosis awaiting liver transplantation (LT) underwent: (1) objective measurement using the LFI and (2) subjective clinician assessment. Spearman's correlation assessed associations between the LFI and clinician assessment; Cox regression with waitlist mortality (death/delisting for sickness); discriminative ability with Concordance(C) statistics. The net reclassification index evaluated the percentage of patients correctly reclassified by adding the LFI to the clinician assessment. RESULTS: Of the 529 patients with cirrhosis, median LFI was 3.8 (range 1.0-7.0) and clinician assessment was 3 (range 0-5). Correlation between LFI and the clinician assessment was modest (ρ=0.38) with high variability by hepatologist (ρ=0.26-0.70). At a median of 11 months, 102 (19%) died/were delisted. Both the LFI (hazard ratio (HR) 2.2, 95% confidence interval (CI) 1.7-2.9) and clinician assessment (HR 1.6, 95% CI 1.3-1.9) were associated with adjusted waitlist mortality risk (P<0.01). The addition of the LFI to the clinician assessment significantly improved mortality prediction over the clinician assessment alone (0.74 vs. 0.68; P=0.02). Compared with the clinician assessment alone, the addition of the LFI correctly reclassified 34% (95% CI 8-53%) of patients to their correct survival status. CONCLUSION: The subjective clinician assessment can predict waitlist mortality in patients with cirrhosis but is subjective and variable by hepatologist. The addition of the LFI to the subjective clinician assessment significantly improved mortality risk prediction, reclassifying 34% of patients. Our data strongly support the incorporation of the objective LFI to anchor our assessments of patients with cirrhosis to enhance our decision-making.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lai JC, Covinsky KE, McCulloch CE, et al. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis. Am J Gastroenterol. 2017. PMID: 29231189. doi:10.1038/ajg.2017.443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。